PD-1 Antibody for Reactive EBV After BMT

Clinical trial NCT04690036 · UNKNOWN

Trial details

NCT number: NCT04690036
Sponsor: Beijing Friendship Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

PD-1 EBV Infection Transplant

Start date: 2021-07-01
Primary completion: 2023-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.